Discover

ELV
Elevance Health, Inc.
416.19
120 x undefined
40 x undefined
bid
ask
+
29.46
7.62%
80 @ 05:26 AM
417.80 +1.61 (0.39%)
Ytd18.72%
1y5.16%
389.56
day range
416.23
273.71
52 week range
426.98
Open389.90Prev Close386.73Low389.56High416.23Mkt Cap90.38B
Vol1.56MAvg Vol1.74MEPS23.60P/E17.64Forward P/E13.24
Beta0.68Short Ratio3.75Inst. Own93.91%Dividend6.88Div Yield1.77
Ex Div Date06-10Earning07-1650-d Avg387.00200-d Avg344.431yr Est418.67

ELV News

Can Carelon Drive Elevance Health's Future Earnings Growth?
zacks.com
Can Carelon Drive Elevance Health's Future Earnings Growth?

Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term

New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
businesswire.com
New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures U

INDIANAPOLIS--(BUSINESS WIRE)--The No Surprises Act was created to protect patients from unexpected

benzinga.com
CNSide Diagnostics Strikes Deal With Elevance Health To Offer CNSide Cerebrospinal Fluid Tumor Cell

CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("P

benzinga.com
Elevance Health Invests $640M In Affordable Housing Over The Past Five Years, Building On More Than

Elevance Health (NYSE:ELV) today announced it has invested $640 million in affordable housing over t

benzinga.com
Elevance Health expects FY2026 GAAP EPS of at least $19.85 per share; Reaffirms Adj EPS of at least

Elevance Health (NYSE:ELV) expects FY2026 GAAP EPS of at least $19.85 per share; Reaffirms Adj EPS o

benzinga.com
Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $465

Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Outperform and raises the pr

benzinga.com
B of A Securities Maintains Buy on Elevance Health, Raises Price Target to $460

B of A Securities analyst Kevin Fischbeck maintains Elevance Health (NYSE:ELV) with a Buy and rai

benzinga.com
Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $404

Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and r

benzinga.com
Truist Securities Maintains Buy on Elevance Health, Raises Price Target to $450

Truist Securities analyst David Macdonald maintains Elevance Health (NYSE:ELV) with a Buy and rai